A shortage no more


TGA announces a feared clonidine shortage is no longer on the cards A forecast shortage of Catapres (clonidine) 150 mcg tablets is no longer expected to occur, the Therapeutic Goods Administration (TGA) has announced. In a release on 6 May, the TGA revealed that a previous announcement by pharmaceutical company Clinect that Catapres (clonidine) 150

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Outcomes have fallen short of expectations: CSL
Next Pharmacy’s pre-budget wish list